Jagsonpal Pharmaceuticals Board recommends dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 14, 2006, inter alia, has recommended dividend of Rs 0.10 only on Equity Shares of Rs 5/- each for the financial year ended March 31, 2006. Jagsonpal Pharmaceuticals Board to recommend dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 14, 2006, to consider the following:1. Approve the audited financial results for Quarterly / year ended on March 31, 20062. Recommend Dividend, if any, for the year ended March 31, 2006. Jagsonpal Pharmaceuticals - FY 06 results by Jun 30, 2006
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Company will be publishing Audited Results for the accounting year 2005-2006 within a period of three months of the close of the accounting year. Jagsonpal Pharmaceuticals - Appointment of Director
Jagsonpal Pharmaceuticals Ltd has informed BSE that Mr. S K Goyal has been appointed as Additional Director of the Company w.e.f. December 30, 2005. Jagsonpal Pharmaceuticals members approve delisting of equity shares
Jagsonpal Pharmaceuticals Ltd has informed BSE that the members at the 26th Annual General Meeting (AGM) of the Company held on September 30, 2005, inter alia, have approved delisting of equity shares from the Delhi Stock Exchange Association Ltd and Ludhiana Stock Exchange Association Ltd. Jagsonpal Pharmaceuticals fixes Book Closure
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 28, 2005 to September 30, 2005 (both days inclusive) for the purpose of Payment of Dividend and Annual General Meeting of the Company. Jagsonpal Pharmaceuticals Board recommends dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors at its meeting held on August 23, 2005, inter alia, has:1. Recommended dividend of Rs 1 (Rupee One only) on equity share of Rs 5/- each for the financial year ended March 31, 2005.2. Approved subject to necessary approvals, voluntary delisting of Equity shares from the Delhi Stock Exchange Association Ltd and the Ludhiana Stock Exchange Association Ltd.... Jagsonpal Pharmaceuticals Board to recommend dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 23, 2005, inter alia, to :1. Recommend dividend, if any, for the year / period ended March 31, 2005.2. Consider delisting from Stock Exchanges at Delhi and Ludhiana. Jagsonpal Pharmaceuticals Board recommends dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that at the meeting of the BoD of the company held on July 15, 2004 the Board recommended dividend of Rs 1 per equity share of Rs 5 each for the fifteen months period ended March 31, 2004. The dividend will be paid on equity share capital to be expanded by subdivision (split of equity share of Rs 10 each into 2 equity shares of Rs 5 each) and bonus in the ratio of 3:1in terms of resolution passed by the members in their EGM held on June 16, 2004. Jagsonpal Pharmaceuticals fixes record date
Jagsonpal Pharmaceuticals Ltd has fixed July 28, 2004 as the Record date for the purpose of Sub Division of existing equity shares from every one equity share of Rs.10/- each into two equity shares of Rs.5/- each and also for the purpose of bonus issue.The Sub-Divided Paid-Up Value & Ex-Bonus Date will be July 20, 2004.